AJMC January 7, 2022
CMS proposed rulemaking Thursday that would pass pharmaceutical price concessions to beneficiaries in Medicare Part D plans and make the medical loss ratio in Medicare Advantage plans more robust.
CMS proposed a draft of rules Thursday aimed at transparency in Medicare Advantage (MA), including improvements for beneficiaries who are dual eligible, and changes to Part D, including passing any price concessions received from pharmaceutical firms to beneficiaries at the pharmacy counter.
“We are dedicated to ensuring older Americans and those with disabilities who are served by the Medicare program have access to quality, affordable health care, including prescription drugs and therapies,” CMS Administrator Chiquita Brooks-LaSure said in a statement. “Today’s proposed actions follow our guiding principles by improving health equity...
Today's Sponsors
Today's Sponsor